High Hampton Holdings Corp. (CSE: HC)(FSE: 0HCN) (“High Hampton” or the “Company”) is pleased to announce that it has entered an extensive strategic planning phase as it awaits the award of the Conditional Use Permit (“CUP”) for its 10.8-acre CoachellaGro Asset located within the Coachella cultivation zone, California. With the legalization of recreational cannabis use in California as of January 1, 2018, the state is rolling out new license application processes, regulations and the track-and-trace system as part of the Marijuana Enforcement Tracking Reporting Compliance (“METRC”).
Although High Hampton’s focus is currently only on the cultivation and distribution of medicinal cannabis as a means to de-risk its asset and provide a higher value product, the Company is utilizing the extensive experience of its senior management team and strategic advisors to ensure compliance with all the latest regulatory provisions by the time it can begin cultivation. Management’s focus remains on preparing for probable policy updates and changes as the new regulations shape the California cannabis market.
As of January 1, 2018, only businesses who have been granted a temporary license through the Department of Public Health’s Manufactured Cannabis Safety Branch (“MCSB”) and the Bureau of Cannabis Control (“BCC”) can legally operate and sell for adult use. While the state is legalizing recreational use, there are still some local governments who have not established or passed ordinances for neither medical or recreational use. High Hampton’s wholly-owned CoachellaGro operation will utilize a 10.8-acre land parcel within a proposed cannabis industrial park in Coachella where by an ordinance, the City of Coachella has set aside 90 acres within which will be a legal framework for the cultivation, production, extraction and transportation of cannabis.
David E. Argudo, CEO of High Hampton, commented:
“I strongly believe that the legalization of medical and recreational marijuana creates a large opportunity for cannabis businesses in California. High Hampton is focused on medicinal cannabis as we move toward the new regulations for both recreational medicinal use. I am proud of the experience within our team to guide us in this important planning stage within the framework of the new regulations, and I am confident that we have the team to meet all future compliance obligations within the evolving regulatory framework such as tracking each of our plants from seed to sale within the deployed track and trace regulatory system METRC.”
About High Hampton Holdings
High Hampton Holdings is a cannabis sector investment company focused on opportunities in California. The Company’s wholly owned subsidiary, CoachellaGro Corp., is a California corporation focused on the development of a 10.8-acre property situated in the proposed cannabis industrial park located in Coachella, California. CoachellaGro is in the application process for a conditional use permit for development of a full-service production facility in order to serve third party state licensed medical marijuana operators. The City of Coachella has been progressive in setting up city ordinance that sets aside 90 acres within which will be a legal framework for the cultivation, production, extraction and transportation of cannabis. The complex is intended to contain all the necessary; security, infrastructure, equipment, labour and skilled management, supplies and ancillary services for a closed loop production process flow.
Click here to connect with High Hampton Holdings Corp. (CSE: HC, FSE: 0HCN) for an Investor Presentation

Source: www.newswire.ca

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less